These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36068547)

  • 1. Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.
    Gao G; Gajewski BJ; Wick J; Beall J; Saver JL; Meinzer C;
    Trials; 2022 Sep; 23(1):754. PubMed ID: 36068547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
    Proper J; Connett J; Murray T
    Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
    Zhang J; Lin R; Chen X; Yan F
    Clin Trials; 2024 Jun; 21(3):308-321. PubMed ID: 38243401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
    Berry SM; Broglio KR; Groshen S; Berry DA
    Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.
    Chen N; Lee JJ
    Biom J; 2019 Sep; 61(5):1219-1231. PubMed ID: 30506747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian hierarchical models for adaptive basket trial designs.
    Chen C; Hsiao CF
    Pharm Stat; 2023; 22(3):531-546. PubMed ID: 36625301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling.
    Zang Y; Guo B; Han Y; Cao S; Zhang C
    Stat Med; 2019 Jul; 38(15):2883-2896. PubMed ID: 30968435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ComPAS: A Bayesian drug combination platform trial design with adaptive shrinkage.
    Tang R; Shen J; Yuan Y
    Stat Med; 2019 Mar; 38(7):1120-1134. PubMed ID: 30419609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials.
    Xiong W; Roy J; Liu H; Hu L
    Contemp Clin Trials; 2024 Jul; 142():107547. PubMed ID: 38688389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.
    Barry WT; Perou CM; Marcom PK; Carey LA; Ibrahim JG
    J Biopharm Stat; 2015; 25(1):66-88. PubMed ID: 24836519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.
    Normington J; Zhu J; Mattiello F; Sarkar S; Carlin B
    Contemp Clin Trials; 2020 Feb; 89():105890. PubMed ID: 31740427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints.
    Chen N; Lee JJ
    Stat Methods Med Res; 2020 Sep; 29(9):2717-2732. PubMed ID: 32178585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies.
    Kaizer AM; Hobbs BP; Koopmeiners JS
    Biometrics; 2018 Sep; 74(3):1082-1094. PubMed ID: 29359450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.